60例外耳道及中耳癌临床回顾性分析
本文选题:癌症 切入点:外耳道 出处:《山东大学》2015年硕士论文 论文类型:学位论文
【摘要】:研究目的:探讨外耳道及中耳癌的临床表现、诊断方法、治疗策略和影响预后的危险因素,以期规范该病治疗措施,提高患者生存时间和生存质量。研究方法:回顾性分析我院2005年4月-2014年2月收治并经病理证实的60例外耳道及中耳癌患者的完整临床资料和随访信息。分析内容包括临床表现、病理类型、影像学表现、临床分期、治疗方案等。采用K-M法绘制各组患者的生存曲线,用COX比例风险模型分析不同危险因素与生存时间的相关性,选用的危险因素包括性别、年龄、T分期、手术切缘、淋巴结转移、面瘫、病理类型等。结果:根据Pittsburgh分期标准,T1期18例,T2期7例,T3期9例,T4期26例。其中,26例行颞骨外侧切除术,30例行颞骨次全切除术,2例于外院行扩大乳突根治术,1例行单纯化疗,1例行单纯放疗。全组患者5年总生存率、无复发生存率分别为67.3%、59.5%,早期(T1、T2期)病例5年生存率、无复发生存率均为100%,T3期病例5年生存率、无复发生存率分别为76.2%、62.2%,T4期病例的5年生存率、无复发生存率分别为32.9%、27.3%。手术加放疗组与单纯手术组病例的5年生存率分别为84.7%、51.3%,5年无复发生存率分别为70.0%、50.8%。在各危险因素中,T分期、手术切缘、有无面瘫、有无硬脑膜受累、病理类型对于预后有明显影响。结论:1、外耳道及中耳癌十分罕见,早期患者的预后情况良好,但是晚期患者的预后较差,因此早期诊断和治疗对于该病的预后至关重要。2、Pittsburgh分期标准是一种科学有效的分期手段,其分期和预后相关,对于指导手术方式的选择具有重要意义。3、我们推荐的最佳治疗方案为手术治疗联合术后放疗。早期患者推荐颞骨外侧切除术,晚期患者推荐颞骨次全切除术,部分可以采用颞骨外侧切除术,不推荐采用局部切除、乳突根治术、颞骨全切除术等。4、T分期为晚期、面神经受累、手术切缘阳性、硬脑膜受累、病理为鳞癌为预后不良的可能危险因素。硬脑膜受累和病理为鳞癌为生存率的独立危险因素,术后辅助放疗为保护因素。
[Abstract]:Objective: to investigate the clinical manifestations, diagnostic methods, treatment strategies and risk factors affecting prognosis of external auditory canal and middle ear cancer, in order to standardize the treatment of the disease. Methods: the complete clinical data and follow-up information of 60 patients with external auditory canal and middle ear cancer admitted from April 2005 to February 2014 in our hospital and confirmed by pathology were analyzed retrospectively. Including clinical manifestations, The survival curve of each group was drawn by K-M method, and the correlation between different risk factors and survival time was analyzed by COX proportional risk model. Age T stage, surgical margin, lymph node metastasis, facial paralysis, Results: according to the Pittsburgh staging criteria, 18 cases with stage T 1 and 7 cases with stage T 3 and 9 cases with stage T 4 were diagnosed as stage T 4. Among them, 26 cases were treated with lateral temporal bone resection and 30 cases with subtotal excision of temporal bone. 2 cases underwent radical mastoidectomy in other hospitals and 1 case underwent radical mastoidectomy. Chemotherapy alone was performed in 1 patient with radiotherapy alone. The overall 5-year survival rate of the patients was 5 years. The 5-year survival rate was 67.3% and 59.5%, respectively. The 5-year survival rate was 100% T _ 3 stage, and the recurrence free survival rate was 76.2%. The 5-year survival rate was 76.2% and 62.2% respectively. The 5-year survival rates were 84.7% and 51.3%, respectively, and the 5-year recurrence free survival rates were 70.0% and 50.8%, respectively. Among the risk factors, T stage, surgical margin, facial palsy and dura mater involvement were found in the operation plus radiotherapy group and the simple operation group, respectively. Conclusion: cancer of external auditory canal and middle ear is very rare. The prognosis of early patients is good, but the prognosis of late patients is poor. Therefore, early diagnosis and treatment are very important to the prognosis of the disease. 2 Pittsburgh staging is a scientific and effective staging method, and its staging is related to prognosis. It is of great significance to guide the choice of surgical methods. 3. The best treatment we recommend is surgery combined with postoperative radiotherapy. Lateral temporal bone resection is recommended for early patients and subtotal temporal bone resection is recommended for late patients. Partial lateral temporal bone resection is not recommended. Radical mastoidectomy and total excision of temporal bone are not recommended for the late stage. The facial nerve is involved, the surgical margin is positive, and the dura mater is involved. Pathology was a possible risk factor for poor prognosis, dura mater involvement and pathology were independent risk factors for survival of squamous cell carcinoma, and postoperative adjuvant radiotherapy was a protective factor.
【学位授予单位】:山东大学
【学位级别】:硕士
【学位授予年份】:2015
【分类号】:R739.61
【相似文献】
中国期刊全文数据库 前10条
1 马忠恕,王宇声,祝威,杜宝东;中耳癌的诊断与治疗[J];实用肿瘤学杂志;2000年02期
2 王新春,邓爱玲;中耳癌20例临床分析[J];中国肿瘤临床;2001年03期
3 郭俊,李尉然,朱保福;中耳癌误诊分析(附10例报告及文献复习)[J];河南肿瘤学杂志;2004年04期
4 王樟煜;戚琼芳;苏志高;钮冠垎;;中耳癌手术治疗21例报告[J];南通大学学报(医学版);1986年01期
5 范加裕;;手术加放疗对中耳癌的疗效观察[J];临床耳鼻咽喉头颈外科杂志;1988年03期
6 李玲香,,陈海燕,李建瑞,徐明义,彭诗东,刘英杰;中耳癌6例临床分析[J];内蒙古医学杂志;1995年06期
7 刘兆华,李朝军;中耳癌[J];临床耳鼻咽喉科杂志;1997年04期
8 杜泽秀;综合治疗对中耳癌的疗效观察[J];华西医学;1997年02期
9 刘公汉,邓仁跃,罗志宏;中耳癌诊治15例报告[J];肿瘤防治研究;1998年02期
10 王槐富,徐刚;中耳癌18例临床分析[J];医学科技;1998年02期
中国重要会议论文全文数据库 前10条
1 贾贤浩;梁琴;迟放鲁;;中耳癌33例临床分析[A];2010全国耳鼻咽喉头颈外科中青年学术会议论文汇编[C];2010年
2 尤慧华;诸葛盼;施海明;;中耳癌误诊误治两例报告[A];浙江省医学会耳鼻咽喉科学分会成立60周年庆典暨2011年浙江省医学会耳鼻咽喉头颈外科学学术年会论文汇编[C];2011年
3 吴保同;;冷冻应用于中耳癌的综合治疗——附30例远期效疗分析[A];上海制冷学会一九八九年年会论文集[C];1989年
4 周水洪;阮凌祥;汪审清;王勤瑛;程可佳;;中耳鳞状细胞癌的影像表现与手术、病理对照研究[A];中华医学会第十次全国耳鼻咽喉-头颈外科学术会议论文汇编(上)[C];2007年
5 程可佳;周水洪;汪审清;;8例外耳道癌及中耳癌诊治分析[A];中华医学会第十次全国耳鼻咽喉-头颈外科学术会议论文汇编(上)[C];2007年
6 韩月臣;樊兆民;徐磊;王海波;;带蒂及游离皮瓣修复中耳癌术后颞部组织缺损[A];全国耳鼻咽喉头颈外科中青年学术会议论文汇编[C];2012年
7 周水洪;;中耳鳞状细胞癌的影像表现与手术、病理对照研究[A];华东六省一市耳鼻咽喉-头颈外科学术会议暨2008年浙江省耳鼻咽喉-头颈外科学术年会论文汇编[C];2008年
8 侯志强;韩月臣;樊兆民;王海波;;双侧异时性中耳癌病例报道2例[A];全国耳鼻咽喉头颈外科中青年学术会议论文汇编[C];2012年
9 王爽;杨新明;;外耳道和中耳癌放射治疗后脑损伤2例并文献复习[A];全国耳鼻咽喉头颈外科中青年学术会议论文汇编[C];2012年
10 周水洪;;中耳鳞状细胞癌的影像表现与手术、病理对照研究[A];2006年浙江省耳鼻咽喉科学术会议论文汇编[C];2006年
中国硕士学位论文全文数据库 前2条
1 张驰;60例外耳道及中耳癌临床回顾性分析[D];山东大学;2015年
2 沈丽芳;十二例外耳道癌和中耳癌临床分析[D];浙江大学;2009年
本文编号:1580740
本文链接:https://www.wllwen.com/yixuelunwen/zlx/1580740.html